By ABIGAIL ZUGER, M.D. I hadn’t seen Larry in a dozen years when he reappeared in my office a few months ago, grinning. We were both grinning. I always liked Larry, even though he was a bit of a hustler, a little erratic in his appointments, a persistent dabbler in a variety of illegal substances. But he was always careful to avoid the hard stuff; he said he had a bad problem as a teenager and was going to stay out of trouble. It was to stay out of trouble that he left town all those years ago, and now he was back, grayer and thinner but still smiling. Then he pulled out a list of the medications he needed, and we both stopped smiling. According to Larry’s list, he was now taking giant quantities of one of the most addictive painkillers around, an immensely popular black-market drug most doctors automatically avoid prescribing except under the most exceptional circumstances. “I got a bad back now, Doc,” Larry said. Doctors hate pain. Let me count the ways. We hate it because we are (mostly) kindhearted and hate to see people suffer. We hate it because it is invisible, cannot be measured or monitored, and varies wildly and unpredictably from person to person. We hate it because it can drag us closer to the perilous zones of illegal practice than any other complaint. And we hate it most of all because unless we specifically seek out training in how to manage pain, we get virtually none at all, and wind up flying over all kinds of scary territory absolutely solo, without a map or a net. Copyright 2013 The New York Times Company

Keyword: Pain & Touch; Aggression
Link ID: 18153 - Posted: 05.14.2013

By Ian Chant Most people make good decisions most of the time. But when drug addiction, disease or brain injury enters the picture, rational thinking can go awry. What if the damaged brain just needed a little reminder of how it feels to choose wisely? Enter the MIMO neural prosthesis, an array of electrodes implanted in the brain that make contact with eight neuron circuits in the prefrontal cor-tex, the brain's command center for decision making. The device can both record the brain activity associated with good choices and stimulate the relevant neurons to get the brain back on track. Although the implant can listen in only on a tiny subset of the neurons in this region, the scientists who developed it, based at Wake Forest Baptist Medical Center, were surprised to discover that they could still pick up signature patterns associated with correct choices, at least in the context of a simple task. The researchers tested the neural prosthesis on monkeys that were trained to move a cursor over a picture on a computer screen to get a food reward. The implant first recorded the brain activity associated with choosing the correct picture. Then the monkeys were given cocaine, and their performance plummeted. But when the implant was switched on to send electric current to the neurons that had earlier been associated with the correct answers, the monkeys immediately started selecting the right pictures again. Some of them did an even better job than they had before receiving cocaine. © 2013 Scientific American,

Keyword: Drug Abuse; Aggression
Link ID: 18141 - Posted: 05.11.2013

Ella Pickover A “helpful” new drug which could help problem drinkers reduce the amount of alcohol they consume will today become available to UK patients. If dependent drinkers take the drug nalmefene and undergo counselling they can cut their consumption levels by 61 per cent, manufacturers said. The pill, also known as selincro, has been licensed for use by health officials and will be available for doctors to prescribe to their patients from today. The drug, which is to be taken once a day, has been licensed for "the reduction of alcohol consumption in adult patients with alcohol dependence without physical withdrawal symptoms and who do not require immediate detoxification". While current drugs help patients to become teetotal, nalmefene helps people with drinking problems to cut back on the amount they drink. The drug works by modulating the reward mechanism in the brain. A clinical trial into the drug helped patients cut the amount they consumed from 12.75 units a day to five units a day - a 61 per cent reduction. And patients who underwent counselling as well as taking the drug reduced their "heavy drinking days" from 23 days a month to nine days a month after undergoing the treatment for six months, researchers said. "The people who we saw in the study were not stereotypical alcoholics, most of them had families and jobs," said drug investigator Dr David Collier, of Barts and The London School of Medicine. © independent.co.uk

Keyword: Drug Abuse
Link ID: 18129 - Posted: 05.07.2013

By Gisela Telis, I’ve seen friends fret over the purported link between aluminum and Alzheimer’s disease and have often wondered if their fears are founded on fact. Should they give up aluminum pans or aluminum-containing antiperspirants? I’ve always heard that aluminum’s health dangers are just hype. So what’s the real deal? The connection between aluminum and Alzheimer’s disease is less a myth than a longstanding scientific controversy. It began in 1965, when researchers discovered that injecting rabbits’ brains with aluminum caused them to develop neurofibrillary tangles, the twisted proteins found in brain cells of patients with Alzheimer’s disease, a degenerative brain disorder that destroys memory and cognition. The finding spurred a rush of research. Just eight years later, a Canadian group studying brain tissue from deceased Alzheimer’s patients found that certain parts of their brains had two to three times more aluminum than a normal brain. By 1980, Daniel Perl and Arnold Brody had managed to actually peer inside human tangle-bearing brain cells — and found aluminum there, too. “That really changed the whole complexion of the thing,” recalls Perl, now a professor of pathology in the Uniformed Services University of the Health Sciences in Bethesda. “I was getting called all the time, because there was so much public interest.” Despite the rise in interest, no one could figure out what this meant for human health. Part of the problem was that scientific techniques were — and still are — too imperfect to provide an answer. Whether they were studying brain cells or conducting population-wide epidemiological studies that tracked aluminum exposure and Alzheimer’s risk, researchers lacked the tools to get very precise or conclusive results. © 1996-2013 The Washington Post

Keyword: Alzheimers; Aggression
Link ID: 18125 - Posted: 05.07.2013

By Dina Fine Maron Almost a decade after manufacturers stopped using certain chemical flame retardants in furniture foam and carpet padding, many of the compounds still lurk in homes. New work to be presented today reaffirms that the chemicals may also still be hurting young children who were exposed before they were born. Researchers investigating the health impacts of prenatal exposure to flame retardants collected blood samples from 309 pregnant women early in their second trimester. Spikes in the levels of one class of flame retardant, polybrominated diphenyl ethers (PBDEs) correlated with behavior and cognition difficulties during early childhood. The researchers tracked children through the first five years of their lives, looking at a battery of tests for IQ and behavior. They found that children of mothers who had high PBDE levels during their second trimester showed cognition deficits when the children were five years old as well as higher rates of hyperactivity at ages two to five. If the mother’s blood had a 10-fold increase in PBDEs, the average five-year-old had about a four-point IQ deficit. “A four-point IQ difference in an individual child may not be perceivable in…ordinary life. However, in a population, if many children are affected, the social and economic impact can be huge due to the shift of IQ distribution and productivity,” says lead author Aimin Chen, an assistant professor of environmental health at the University of Cincinnati College of Medicine. The findings, based on women and children from Cincinnati, will be presented May 6 at the annual meeting of the Pediatric Academic Societies in Washington, D.C. The unpublished results have been submitted to a peer-reviewed journal, but the paper has not yet been accepted. © 2013 Scientific American

Keyword: Intelligence; Aggression
Link ID: 18124 - Posted: 05.07.2013

The short answer is no. But your question gets to the heart of an important problem that we have in this country: that all medications are approved by the Food and Drug Administration on the basis of relatively short-term studies, even though many are used long-term for medical and psychiatric disorders that are chronic, if not lifelong. The F.D.A. approves antidepressants like selective serotonin re-uptake inhibitors, or S.S.R.I.’s, if the drug beats a placebo in two randomized clinical trials that typically last 4 to 12 weeks and involve a few hundred patients. Longer-term maintenance studies, usually lasting one to two years, indicate that S.S.R.I.’s do not cause any serious harm, though they have plenty of side effects, like weight gain and sexual dysfunction. Once a drug hits the market, we have only a voluntary system of reporting adverse effects in the United States; there are no systematic long-term studies of any drug lasting 10 or more years. Still, S.S.R.I.’s have been used since the late 1980s and given to more than 40 million Americans, so it’s reasonable to say that if these drugs caused any significant toxic effects, we would have seen many such reports. Instead, we have some anecdotal reports claiming a wide range of S.S.R.I.-related toxicity, but one cannot know from these reports whether the symptoms are related to S.S.R.I. use or to medical illnesses that happen to develop over time in people taking these drugs. Copyright 2013 The New York Times Company

Keyword: Depression
Link ID: 18116 - Posted: 05.04.2013

Distinct patterns of brain activity are linked to greater rates of relapse among alcohol dependent patients in early recovery, a study has found. The research, supported by the National Institutes of Health, may give clues about which people in recovery from alcoholism are most likely to return to drinking. "Reducing the high rate of relapse among people treated for alcohol dependence is a fundamental research issue," said Kenneth R. Warren, Ph.D., acting director of the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of NIH. "Improving our understanding of the neural mechanisms that underlie relapse will help us identify susceptible individuals and could inform the development of other prevention strategies." Using brain scans, researchers found that people in recovery from alcoholism who showed hyperactivity in areas of the prefrontal cortex during a relaxing scenario were eight times as likely to relapse as those showing normal brain patterns or healthy controls. The prefrontal brain plays a role in regulating emotion, the ability to suppress urges, and decision-making. Chronic drinking may damage regions involved in self-control, affecting the ability to regulate cravings and resist relapse. Findings from the study, which was funded by NIAAA, appear online at the JAMA Psychiatry website.

Keyword: Drug Abuse; Aggression
Link ID: 18106 - Posted: 05.02.2013

By Scott O. Lilienfeld and Hal Arkowitz A German children's book from 1845 by Heinrich Hoffman featured “Fidgety Philip,” a boy who was so restless he would writhe and tilt wildly in his chair at the dinner table. Once, using the tablecloth as an anchor, he dragged all the dishes onto the floor. Yet it was not until 1902 that a British pediatrician, George Frederic Still, described what we now recognize as attention-deficit hyperactivity disorder (ADHD). Since Still's day, the disorder has gone by a host of names, including organic drivenness, hyperkinetic syndrome, attention-deficit disorder and now ADHD. Despite this lengthy history, the diagnosis and treatment of ADHD in today's children could hardly be more controversial. On his television show in 2004, Phil McGraw (“Dr. Phil”) opined that ADHD is “so overdiagnosed,” and a survey in 2005 by psychologists Jill Norvilitis of the University at Buffalo, S.U.N.Y., and Ping Fang of Capitol Normal University in Beijing revealed that in the U.S., 82 percent of teachers and 68 percent of undergraduates agreed that “ADHD is overdiagnosed today.” According to many critics, such overdiagnosis raises the specter of medicalizing largely normal behavior and relying too heavily on pills rather than skills—such as teaching children better ways of coping with stress. Yet although data point to at least some overdiagnosis, at least in boys, the extent of this problem is unclear. In fact, the evidence, with notable exceptions, appears to be stronger for the undertreatment than overtreatment of ADHD. © 2013 Scientific American,

Keyword: ADHD; Aggression
Link ID: 18105 - Posted: 05.02.2013

By ALAN SCHWARZ FRESNO, Calif. — Lisa Beach endured two months of testing and paperwork before the student health office at her college approved a diagnosis of attention deficit hyperactivity disorder. Then, to get a prescription for Vyvanse, a standard treatment for A.D.H.D., she had to sign a formal contract — promising to submit to drug testing, to see a mental health professional every month and to not share the pills. “As much as it stunk, it’s nice to know, ‘O.K., this is legit,' ” said Ms. Beach, a senior at California State University, Fresno. The rigorous process, she added, has deterred some peers from using the student health office to obtain A.D.H.D. medications, stimulants long abused on college campuses. “I tell them it takes a couple months,” Ms. Beach said, “and they’re like, ‘Oh, never mind.’ ” Fresno State is one of dozens of colleges tightening the rules on the diagnosis of A.D.H.D. and the subsequent prescription of amphetamine-based medications like Vyvanse and Adderall. Some schools are reconsidering how their student health offices handle A.D.H.D., and even if they should at all. Various studies have estimated that as many as 35 percent of college students illicitly take these stimulants to provide jolts of focus and drive during finals and other periods of heavy stress. Many do not know that it is a federal crime to possess the pills without a prescription and that abuse can lead to anxiety, depression and, occasionally, psychosis. Although few experts dispute that stimulant medications can be safe and successful treatments for many people with a proper A.D.H.D. diagnosis, the growing concern about overuse has led some universities, as one student health director put it, “to get out of the A.D.H.D. business.” © 2013 The New York Times Company

Keyword: ADHD; Aggression
Link ID: 18102 - Posted: 05.01.2013

By ABIGAIL ZUGER, M.D. Addiction swallows lives whole, and not only with overdose, illness and concentric cycles of rehab and relapse. A less onerous but still tenacious kind of post-traumatic stress disorder may develop as well, with recovered addicts and their families compulsively reliving the past in private — or, like David Sheff and his son Nic, in public. In the last five years the two have written a small library of memoirs centered on Nic’s battle with substance use, with two by Nic (now 31, and sober) and the 2008 best seller by his father, “Beautiful Boy.” Now comes “Clean,” less memoir than guide for those just entering the terrain Mr. Sheff knows so well. If the book represents a certain redundancy of subject, its likely audience — those who must watch as friends and family spiral away — cannot hear too many sympathetic reiterations of the same truths. In “Clean,” Mr. Sheff changes perspective, writing as advocate and journalist rather than distraught father. Still, his story line recreates that of “Beautiful Boy,” tracing the trajectory of addiction from cradle to rehab and beyond with the same question in mind: How does a promising cleareyed kid from a good family wind up in an inconceivable sea of trouble? His answer, bludgeoned home with the repetitive eloquence of the missionary, is entirely straightforward: The child is ill. Addiction must be considered a disease, as devoid of moral overtones as diabetes or coronary artery disease, just as amenable as they are to scientific analysis, and just as treatable with data-supported interventions, not hope, prayer or hocus-pocus. © 2013 The New York Times Company

Keyword: Drug Abuse
Link ID: 18098 - Posted: 04.30.2013

By Cheryl Knepper Substance abuse and dependence rarely occur in a vacuum. Today’s addict is faced with a multitude of issues that may co-exist and compromise recovery. Co-existing addictions/compulsive behaviors such as drugs and alcohol, pathological gambling, sex, food, work, internet and gaming can become chronic and progressive if left unidentified and untreated. Many of these addictions don’t only coexist, but interact, reinforce and fuse together becoming part of a package known as Addiction Interaction. The term “Addiction Interaction Disorder” was introduced by Patrick Carnes PhD in 2011. Caron Treatment Centers conducted a research study among adult patients with drug and alcohol addictions to determine what percentage may be at risk for sex and love addiction. The 485 participants were given the SAST-R (Sexual Addiction Screening Tool-Revised a 45 item forced choice (Yes/No) instrument): Carnes, Green & Carnes, 2010. The findings of this study indicated that 21 percent of individuals being treated for primary substance dependence scored at risk. Another interesting finding from the study showed a higher percentage of cannabis, cocaine and amphetamine abuse or dependence diagnosis in the individuals that scored at-risk for sexual addiction. In addition, at-risk individuals had higher percentages of mood disorder, PTSD and eating disorder diagnoses. © 2013 Scientific American

Keyword: Drug Abuse
Link ID: 18097 - Posted: 04.30.2013

By Nathan Seppa The tobacco and fruit mixture smoked in public hookah bars might be considerably more dangerous than its pleasant scent would suggest. An analysis of people who smoked from water pipes three times a day finds that the pipes deliver more carbon monoxide and benzene, a carcinogen, than does smoking half a pack of cigarettes daily. In an upcoming issue of Cancer Epidemiology, Biomarkers & Prevention, researchers document those and several other cancer-causing compounds that showed up in urine tests of the water-pipe smokers. The research calls into question a common assumption: that hookahs are safe. “This is a great addition to the literature,” says Thomas Eissenberg, a psychologist at Virginia Commonwealth University in Richmond. He and his colleagues had previously found toxic substances in hookah smoke. The new paper extends his findings by detecting carcinogens and other bad actors in water-pipe smokers themselves, he says. Hookah smoking goes back hundreds of years in India, the Middle East and North Africa, but it is newer in parts of Europe and North America. The substances heated in a hookah vary. In the study, researchers used pastes chosen by the participants that were 5 to 10 percent tobacco combined with honey, molasses and bits of fruit. This paste goes in the bowl of the pipe, which is covered with a perforated piece of aluminum foil and topped with a burning piece of charcoal, says study coauthor Peyton Jacob III, a research chemist at the University of California, San Francisco. © Society for Science & the Public 2000 - 2013

Keyword: Drug Abuse
Link ID: 18088 - Posted: 04.29.2013

By KATIE THOMAS With the diagnosis of autism on the rise and drug companies facing major setbacks in developing successful treatments, the University of California, Los Angeles will lead a $9 million effort financed by the National Institute of Mental Health to find effective drugs, officials said Wednesday. Under a contract with the institute, U.C.L.A. will form a network of researchers at other academic centers that will try to identify promising new and older drug compounds quickly, and conduct early tests to see if they merit additional investment. The program, part of the “Fast Fail” initiative at the institute, aims to determine within weeks whether a drug works, rather than the years it traditionally takes to evaluate a new drug. “The whole idea is just getting much better in these early phases at identifying drugs that are going to be efficacious and safe, and thereby greatly speeding the development of effective new therapies and reducing the overall cost,” said Dr. James McCracken, who is leading the effort at U.C.L.A. as director of the division of child and adolescent psychiatry at the Semel Institute for Neuroscience and Human Behavior. The number of diagnosed cases of autism, Asperger’s syndrome and related disorders in children has been growing in recent years, largely because of increased awareness. A recent report by the Centers for Disease Control and Prevention and the Health Resources and Services Administration concluded that one in 50 children aged 6 to 17 had been found to have autism or a related disorder, a 72 percent increase since 2007. Although more cases are being diagnosed, no drugs are approved to treat the core symptoms of the disorders, which are characterized by delays in developing effective communication and social skills. Other drugs often prescribed to people with the disorders treat difficult behaviors like aggressiveness, hyperactivity and irritability. © 2013 The New York Times Company

Keyword: Autism
Link ID: 18070 - Posted: 04.25.2013

By DONALD G. McNEIL Jr. Konzo, a disease that comes from eating bitter cassava that has not been prepared properly — that is, soaked for days to break down its natural cyanide — has long been known to cripple children. The name, from the Yaka language of Central Africa, means “tied legs,” and victims stumble as if their knees were bound together. Now researchers have found that children who live where konzo is common but have no obvious physical symptoms may still have mental deficits from the illness. Cassava, also called manioc or tapioca, is eaten by 800 million people around the world and is a staple in Africa, where bitter varieties grow well even in arid regions. When properly soaked and dried, and especially when people have protein in their diet, bitter cassava is “pretty safe,” said Michael J. Boivin, a Michigan State psychiatry professor and lead author of a study published online by Pediatrics. “But in times of war, famine, displacement and hardship, people take shortcuts.” In the Democratic Republic of Congo, Dr. Boivin and colleagues gave tests of mental acuity and dexterity to three groups of children. Two groups were from a village near the Angolan border with regular konzo outbreaks: Half had leg problems; half did not but had cyanide in their urine. The third was from a village 125 miles away with a similar diet but little konzo because residents routinely detoxified cassava before cooking it. © 2013 The New York Times Company

Keyword: Neurotoxins; Aggression
Link ID: 18067 - Posted: 04.24.2013

by Scicurious Mmmmm beer! Just a sip is enough to prime the brain's dopamine addiction circuits, if reports of a new study are to be believed. Photograph: Johnny Green/PA It's been a long day at work, followed by a long workout. I'm tired, and all I really want is to relax with a beer. I grab one out of the fridge and take a sip. I feel better already. A new study tells us that this is due to dopamine, a neurotransmitter that plays an important role in things like motivation and reward. Drugs of abuse, such as cocaine, increase dopamine levels in areas of the brain associated with the expectation of reward, such as the ventral striatum, and this increase is part of what makes them feel so good, and do so bad. But dopamine can also signal the expectation of something that might be rewarding. This means that as we learn that some things are rewarding, like, say, beer, we begin to respond, not only to the alcohol, but to the cues that alcohol is coming: to the beer bottles, the glass, or the taste. And taste is what this study looked at. The authors took 49 male beer drinkers and divided them up into three groups: those with a family history of alcoholism, those without, and those who didn't know. They used positron emission tomography (PET) to examine how the dopamine in their brains responded to a taste of beer. The big effect? The mere taste of your favourite beer (15 millilitres – not enough to get any effects of the alcohol) produces an increase in dopamine in the ventral striatum, as well as an increased desire to … drink more beer. This suggests that a cue (the taste) produces a sign of reward expectation long before the alcohol hits your system. And the effect of the taste of beer on dopamine in the ventral striatum was larger in people who had a family history of alcohol abuse. What's not to love! It's beer! It's dopamine! It's brain scans! Of course the media got excited. © 2013 Guardian News and Media Limited

Keyword: Drug Abuse; Aggression
Link ID: 18053 - Posted: 04.20.2013

By David Brown, As a bioterrorism agent, ricin has the advantage of being easily made and highly potent. But there have been few fatal cases in the past 50 years, and there is little precise information about the substance’s effects on human beings. Ricin is not a microbe. It does not grow inside the body and can’t be passed from person to person. It is a toxin produced by the castor bean plant. When the beans are crushed for oil, the compound is left behind in the mashed material, of which more than a million tons is produced around the world each year. “It is a plant that grows wild throughout much of North America. You can buy the seeds online,” said Jennifer A. Oakes, a physician and expert in ricin poisoning at Albany Medical College. “It doesn’t take much to get a fatal dose. Somebody could do this in their house if they are motivated to.” Ricin’s best-known victim is Georgi Markov, a Bulgarian journalist who was stabbed by an umbrella on a London street in 1978. The umbrella’s tip injected a tiny metal capsule containing ricin into Markov’s leg. He died three days later. Apart from him, the only other ricin fatalities in the past 50 years have been a few suicides and accidental poisonings, usually after castor beans were eaten but at least once by injecting a crude extract. A person needs to take about 1,000 times as much ricin by mouth as by other routes to get a fatal dose. Unlike nerve agents and botulinum toxin, which disrupt nerve transmission and can cause death in minutes, ricin acts slowly. It stops the synthesis of proteins in cells, killing them over hours or days. A person dies of multi-organ failure as cells break down and fluid and essential electrolytes are lost. © 1996-2013 The Washington Post

Keyword: Neurotoxins
Link ID: 18043 - Posted: 04.18.2013

A study by researchers at the National Institutes of Health gives insight into changes in the reward circuitry of the brain that may provide resistance against cocaine addiction. Scientists found that strengthening signaling along a neural pathway that runs through the nucleus accumbens — a region of the brain involved in motivation, pleasure, and addiction — can reduce cocaine-seeking behavior in mice. Research suggests that about 1 in 5 people who use cocaine will become addicted, but it remains unclear why certain people are more vulnerable to drug addiction than others. “A key step in understanding addiction and advancing treatment is to identify the differences in brain connectivity between subjects that compulsively take cocaine and those who do not,” said Ken Warren, Ph.D., acting director of the National Institute on Alcohol Abuse and Alcoholism (NIAAA). Researchers at NIAAA, part of NIH, conducted the study. “Until now, most efforts have focused on finding traits associated with vulnerability to develop compulsive cocaine use. However, identifying mechanisms that promote resilience may prove to have more therapeutic value,” said the paper’s senior author, Veronica Alvarez, Ph.D., acting chief of the Section on Neuronal Structure in the NIAAA Laboratory for Integrative Neuroscience. The study is available on the Nature Neuroscience website ahead of print. In the study, mice were conditioned to receive an intravenous dose of cocaine each time they poked their nose into a hole in their enclosure. Cocaine was then made unavailable for periods of time during the day. Some of the mice would stop seeking the drug once it was removed while others would obsessively continue to poke the hole in an effort to obtain the drug.

Keyword: Drug Abuse; Aggression
Link ID: 18041 - Posted: 04.16.2013

By Steven E. Hyman During the past three years the global pharmaceutical industry has significantly decreased its investment in new treatments for depression, bipolar disorder, schizophrenia, and other psychiatric disorders.1 Some large companies, such as GlaxoSmithKline, have closed their psychiatric laboratories entirely. Others, such as Pfizer, have markedly decreased the size of their research programs. Yet others, such as AstraZeneca, have brought their internal research to a close and are experimenting with external collaborations on a smaller scale. This retreat has occurred despite the fact that mental disorders are not only common worldwide, but also increasingly recognized by healthcare systems. There is, moreover, vast unmet medical need, meaning that many individuals with mental disorders remain symptomatic and often disabled despite existing treatments. For example, people suffering with the depressed phase of bipolar disorder often continue to experience severe symptoms even when they take multiple medications with serious side effects. For some significantly disabling conditions, such as the core social deficits of autism and the cognitive impairments of schizophrenia, there simply are no effective treatments. Because mental disorders are highly prevalent and our ability to treat them remains limited, these illnesses cause enormous societal burden. In aggregate, they are the world’s leading cause of disability.2 In addition, this retreat has happened despite the fact that different classes of psychiatric drugs have been among the industry’s most profitable products during the last several decades—and despite the fact that, according to Medco Health Solutions, one in five American adults now takes at least one psychiatric drug. Among the earliest commercial successes were the Valium-like benzodiazepines, used both as tranquilizers and as sleeping pills. These were followed by the Prozac-like selective serotonin reuptake inhibitor (SSRI) antidepressants. Most recently, “second-generation” antipsychotic drugs have been among the global revenue leaders for the pharmaceutical industry, serious side effects notwithstanding. That’s why it’s surprising that almost all industry research dollars are invested in cancer, metabolism, autoimmunity, and other disease areas. Copyright 2013 The Dana Foundation

Keyword: Depression; Aggression
Link ID: 18031 - Posted: 04.13.2013

By Meghan Rosen Whether you’re rocking out to Britney Spears or soaking up Beethoven’s classics, you may be enjoying music because it stimulates a guessing game in your brain. This mental puzzling explains why humans like music, a new study suggests. By looking at activity in just one part of the brain, researchers could predict roughly how much volunteers dug a new song. When people hear a new tune they like, a clump of neurons deep within their brains bursts into excited activity, researchers report April 12 in Science. The blueberry-sized cluster of cells, called the nucleus accumbens, helps make predictions and sits smack-dab in the “reward center” of the brain — the part that floods with feel-good chemicals when people eat chocolate or have sex. The berry-sized bit acts with three other regions in the brain to judge new jams, MRI scans showed. One region looks for patterns, another compares new songs to sounds heard before, and the third checks for emotional ties. As our ears pick up the first strains of a new song, our brains hustle to make sense of the music and figure out what’s coming next, explains coauthor Valorie Salimpoor, who is now at the Baycrest Rotman Research Institute in Toronto. And when the brain’s predictions are right (or pleasantly surprising), people get a little jolt of pleasure. All four brain regions work overtime when people listen to new songs they like, report the researchers, including Robert Zatorre of the Montreal Neurological Institute at McGill University © Society for Science & the Public 2000 - 2013

Keyword: Hearing; Aggression
Link ID: 18030 - Posted: 04.13.2013

By Puneet Kollipara Rats that will go to great lengths to get a cocaine fix might blame a group of sluggish neurons. Controlling the problem may come down to a flick of a light switch: Stimulating those brain cells with lasers reduces the addicted rats’ cocaine use, researchers report in the April 4 Nature. “It's an outstanding piece of work,” says neuroscientist A.J. Robison of Michigan State University, who wasn’t involved in the study. The findings could help researchers better understand the role of neural circuitry in drug addiction in humans, he says. Scientists know that when certain neurons fire less frequently in the prelimbic cortex, a brain region that handles impulse control and reward-driven behavior, a person’s self-control can decrease. But researchers didn’t know whether using cocaine chronically could make the neurons drowsy to begin with, and whether that sluggishness could also promote drug use in spite of ill consequences. Billy Chen, then of the National Institutes of Health, and colleagues trained rats to take cocaine. The rats learned to press levers to receive a dose of drug through an IV. After about two months, researchers started giving the rats shocks roughly one-third of the time when the animals pressed the levers. Most of the rats stopped taking cocaine, but about 30 percent continued. These were compulsive cocaine users, says coauthor Antonello Bonci, a neuroscientist at the NIH’s National Institute on Drug Abuse. © Society for Science & the Public 2000 - 2013

Keyword: Drug Abuse
Link ID: 17991 - Posted: 04.05.2013